Skip to main content

Table 2 Clinical characteristics of the NUP98 high and low samples within the in-house TNBC gene expression datasets

From: NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

  Nup98 low (N = 30) Nup98 high (N = 30)
Age < 40 3 5
40–49 11 12
50–59 6 6
60+ 10 7
T code 1 11 9
2–4 19 21
N code 0 18 21
1–3 12 9
LVI present 14 15
Not seen 16 15